上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1165Please respect copyright.PENANAJsjIvyNa3I
1165Please respect copyright.PENANA0o7onpawbR
上集:https://www.penana.com/article/4711251165Please respect copyright.PENANAPticWqKc5h
1165Please respect copyright.PENANAvmMWpip32z
1165Please respect copyright.PENANAqMk5xNkbb4
1165Please respect copyright.PENANAta8M1qLH06
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1165Please respect copyright.PENANAwT1vckQRFo
1165Please respect copyright.PENANAXl1SrElqqH
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1165Please respect copyright.PENANAtA2SOroqwM
1165Please respect copyright.PENANAE3icdLRV3E
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1165Please respect copyright.PENANAl2B4kDHbM5
1165Please respect copyright.PENANAAVpzTLoIJm
1165Please respect copyright.PENANASdYDmS0UlQ
1165Please respect copyright.PENANAEsPyYlzw0l
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1165Please respect copyright.PENANAS7uUHZTAY6
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1165Please respect copyright.PENANA2i9l26Xb24
1165Please respect copyright.PENANAo6Uja3R7rj
忘記甚麼是Neoantigen的話,可重溫上一集。1165Please respect copyright.PENANAtROANTosei
1165Please respect copyright.PENANAQ6PJdAUFCE
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1165Please respect copyright.PENANAirZzQMWl0n
1165Please respect copyright.PENANAkW7qXZCkQ7
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1165Please respect copyright.PENANAvVE25NccFn
1165Please respect copyright.PENANAZHjD7jtoLS
1165Please respect copyright.PENANA8J6ph4oGNO
1165Please respect copyright.PENANAkqlXwNf5X5
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1165Please respect copyright.PENANAQPbrKfz75P
1165Please respect copyright.PENANAM83Vq5pUxn
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1165Please respect copyright.PENANAGcUdqHxknG
1165Please respect copyright.PENANAWtYazmiPkL
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1165Please respect copyright.PENANA3jV9hYxRM7
1165Please respect copyright.PENANAjMPtCA1M01
1165Please respect copyright.PENANALvQe4pXXS4
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1165Please respect copyright.PENANApBAyimW47h
1165Please respect copyright.PENANATboycIlln6
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1165Please respect copyright.PENANAvzrUzKWMxE
1165Please respect copyright.PENANAkyWbii53mb
1165Please respect copyright.PENANA0PG8eALnFQ
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1165Please respect copyright.PENANAkAgFgJI4uk
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1165Please respect copyright.PENANAGG91W0bRND
1165Please respect copyright.PENANARkBekiWQLn
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1165Please respect copyright.PENANAcKOIVrsHJS
1165Please respect copyright.PENANAPt9wSPUBNl
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1165Please respect copyright.PENANAyhbCo6fxSE
1165Please respect copyright.PENANAtw7Td5g9ow
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1165Please respect copyright.PENANA5HvGnZhaGA
1165Please respect copyright.PENANAoEB1ZrTG2W
1165Please respect copyright.PENANAVPZMUjUTe8
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1165Please respect copyright.PENANAVhezrjUDX4
1165Please respect copyright.PENANARf9eVQxbM0
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1165Please respect copyright.PENANALX856NRytM
1165Please respect copyright.PENANAMPSHwgaA4A
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1165Please respect copyright.PENANAReHp3X1bXV
1165Please respect copyright.PENANACf8yhNBMRx
Link:1165Please respect copyright.PENANAhERSYMFZkW
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1165Please respect copyright.PENANAeGuOpY4E04
1165Please respect copyright.PENANA0EjJLcgJ0G
1165Please respect copyright.PENANAS5E8cNd0f8
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1165Please respect copyright.PENANAcbUkZGWmpV